Last fall, the Premier Hockey Federation, formerly the National Women’s Hockey League, debuted a new inclusion policy for transgender athletes. The move came shortly after the league announced it would be changing its name to be more gender inclusive. The new policy was significantly different from the previous one, mainly in its provision of a therapeutic use exemption (TUE) for testosterone — a huge step forward for transmasculine athletes. At least one athlete, Harrison Browne, had left the league so he could begin hormone treatment.
But the PHF’s policy also came with another new, controversial clause: While the league no longer requires transfeminine athletes to be on hormone therapy, it does stipulate that they must be "living in their identity for two years" in order to play in the PHF.
